Garland Capital Management’s Organon & Co OGN Stock Holding History

Garland Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-162,797	Closed	-$2.83M	–	34
2023 Q3	$2.83M	Buy	162,797 +180	+0.1%	+$3.75K	1.99%	29
2023 Q2	$3.38M	Buy	162,617 +3,420	+2%	+$74.3K	2.28%	28
2023 Q1	$3.74M	Sell	159,197 -5,700	-3%	-$153K	2.54%	24
2022 Q4	$4.61M	Buy	164,897 +6,785	+4%	+$173K	3%	18
2022 Q3	$3.7M	Buy	158,112 +2,975	+2%	+$89.8K	3.22%	19
2022 Q2	$5.24M	Buy	155,137 +3,055	+2%	+$107K	3.91%	11
2022 Q1	$5.31M	Sell	152,082 -2	-0%	-$68	3.52%	17
2021 Q4	$4.63M	Sell	152,084 -16,360	-10%	-$533K	3.19%	17
2021 Q3	$5.52M	Buy	168,444 +750	+0.4%	+$24K	3.95%	10
2021 Q2	$5.07M	Buy	+167,694	New	+$5.52M	3.57%	14

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Garland Capital Management's OGN Position: Q4 2023 in Review

Garland Capital Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 162,797 shares — an estimated $2.83M sold.

Garland Capital Management first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $5.52M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Garland Capital Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Garland Capital Management sold 162,797 Organon & Co shares in Q4 2023, an estimated $2.83M.
Garland Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Garland Capital Management's Organon & Co position peaked at $5.52M in Q3 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Garland Capital Management's 13F filing for Q4 2023, filed 29 Jan 2024.